[15 February 2012]
Products Affected - Description
Metronidazole tablets, Major
250 mg, 100 count, unit dose (NDC 00904-1453-61) - discontinued
Metronidazole tablets, Watson
250 mg, 100 count (NDC 00591-3969-01) - discontinued
500 mg tablets, 50 count, robot-ready (NDC 00591-3970-50) - discontinued
Reason for the Shortage
- Watson stated the reason for the shortage was supply constraints.
- Teva discontinued their metronidazole unit dose presentations.
- Major discontinued their metronidazole unit dose presentation.
Available Products
Metronidazole, Teva
250 mg tablets, 100 count (NDC 50111-0333-01)
250 mg tablets, 250 count (NDC 50111-0333-06)
250 mg tablets, 500 count (NDC 50111-0333-02)
500 mg tablets, 100 count (NDC 50111-0334-01)
500 mg tablets, 500 count (NDC 50111-0334-02)
375 mg capsules, 50 count (NDC 50111-0884-05)
Metronidazole, UDL
250 mg tablets, 25 count, robot-ready (NDC 51079-0122-19)
250 mg tablets, 100 count, unit dose (NDC 51079-0122-20)
500mg tablets, 25 count, robot-ready (NDC 51079-0126-19)
500 mg tablets, 100 count, unit dose (NDC 51079-0126-20)
Metronidazole, Watson
250 mg tablets, 100 count (NDC 00591-2521-01)
250 mg, 250 count (NDC 00591-3969-25)
250 mg tablets, 500 count (NDC 00591-3969-05)
500 mg, 50 count, robot-ready (NDC 00591-2522-50)
500 mg tablets, 500 count (NDC 00591-3970-05)
Flagyl, Pfizer
250 mg tablets, 50 count (NDC 00025-1831-50)
250 mg tablets, 100 count (NDC 00025-1831-31)
500 mg tablets, 50 count (NDC 00025-1821-50)
500 mg tablets, 100 count (NDC 00025-1821-31)
750 mg extended-release tablets, 30 count (NDC 00025-1961-30)
375 mg capsules, 50 count (NDC 00025-1942-50)
Estimated Resupply Dates
All products are now available.
Related Shortages
Updated
February 15, 2012; December 22, 2011; November 30, 2011; November 16, 2011; November 3, 2011; August 31, 2011; July 26, 2011; July 13, 2011; June 16, 2011; May 19, 2011; April 15, 2011; March 31, 2011; March 25, 2011; March 4, 2011; March 2, 2011; February 23, 2011; February 17, 2011; February 16, 2011; February 9, 2011; February 1, 2011; January 26, 2011; January 20, 2011; January 14, 2011, University of Utah, Drug Information Service. Copyright 2012, Drug Information Service, University of Utah, Salt Lake City, UT.
Disclaimer
This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.
« Back to Drug Shortage Product Bulletins